semaglutide merck GLP-1s Semaglutide | The Merck Index

Hu, M., Li, J., Baker, P

The Retatrutide pen designs in current trials lean toward a multi-dose dial-in system, similar to the Ozempic design, or an ultra-refined autoinjector

27 (S2)

STEP 2 confirmed efficacy in diabetic populations (9.6% weight reduction)

"After the first half year the amount of wight loss may slow down, reaching maximum weight loss at about one year of continuous use, but you then need to keep taking the drug in a sufficient dose." While the effectiveness of semaglutide in the very-long term is unclearas the drugs are relatively new on the marketThomsen said some patients may need to keep taking semaglutide indefinitely

There is a small subset of patients who are very diligent in implementing lifestyle changes and still dont see the weight loss they are working towards